Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Orchitis : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Acknowledgments
References

Related Articles
Epididymitis

Hernias

Testicular Torsion




Patient Education
Men's Health Center

Bacterial and Viral Infections Center

Sexually Transmitted Diseases Center

Orchitis Overview

Orchitis Causes

Orchitis Symptoms

Orchitis Treatment

Mumps Overview

Sexually Transmitted Diseases Overview




Author: Mark B Mycyk, MD, Assistant Professor, Department of Emergency Medicine, Northwestern University Feinberg School of Medicine; Consulting Staff, Department of Emergency Medicine and Director of Clinical Toxicology and Toxicological Research, Northwestern Memorial Hospital

Mark B Mycyk is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Medical Toxicology, and Society for Academic Emergency Medicine

Editors: Eric Kardon, MD, FACEP, Consulting Staff, Department of Emergency Medicine, Athens Regional Medical Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Richard Sinert, DO, Associate Professor of Emergency Medicine, Clinical Assistant Professor of Medicine, State University of New York College of Medicine; Consulting Staff, Department of Emergency Medicine, Kings County Hospital Center; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School

Author and Editor Disclosure

Synonyms and related keywords: orchitis, viral orchitis, bacterial orchitis, epididymo-orchitis, mumps orchitis, testicular pain, testicular swelling, inflammation of the testis, viral mumps infection, epididymitis, testicular atrophy, benign prostatic hypertrophy, BPH, parotitis, testicular edema



Background

Orchitis is an acute inflammatory reaction of the testis secondary to infection. Most cases are associated with a viral mumps infection; however, other viruses and bacteria can cause orchitis.

Pathophysiology

Hippocrates first reported the syndrome in the 5th century BC. While the more common epididymo-orchitis is bacterial in origin, isolated orchitis usually has a viral etiology.

Frequency

United States

Approximately 20% of prepubertal patients with mumps develop orchitis. This condition rarely occurs in postpubertal males with mumps. Bacterial orchitis is even more rare and is usually associated with a concurrent epididymitis.

Mortality/Morbidity

  • Unilateral testicular atrophy occurs in 60% of patients with orchitis.
  • Sterility is rarely a consequence of unilateral orchitis.
  • Despite some anecdotal reports, little evidence supports an increased likelihood of developing a testicular tumor after an episode of orchitis.

Age

  • In mumps orchitis, 4 out of 5 cases occur in prepubertal males (younger than 10 years).
  • In bacterial orchitis, most cases are associated with epididymitis (epididymo-orchitis), and they occur in sexually active males older than 15 years or in men older than 50 years with benign prostatic hypertrophy (BPH).



History

  • Orchitis is characterized by testicular pain and swelling.
  • The course is variable and ranges from mild discomfort to severe pain.
  • Associated systemic symptoms
    • Fatigue

    • Malaise

    • Myalgias

    • Fever and chills

    • Nausea

    • Headache

  • Mumps orchitis follows the development of parotitis by 4-7 days.
  • Obtain a sexual history, when appropriate.

Physical

  • Testicular examination
    • Testicular enlargement

    • Induration of the testis

    • Tenderness

    • Erythematous scrotal skin

    • Edematous scrotal skin

    • Enlarged epididymis associated with epididymo-orchitis

  • Rectal examination
    • Soft boggy prostate (prostatitis) often associated with epididymo-orchitis

    • Stool for occult blood

  • Other
    • Parotitis

    • Fever

Causes

  • Most commonly, mumps causes isolated orchitis.

    • The onset of scrotal pain and edema is acute.
    • Because mumps orchitis is responsible for most cases of isolated orchitis, diagnosis in the ED usually is based on a reported history of a recent mumps infection or parotitis with a presentation of testicular edema.
    • Mumps orchitis presents unilaterally in 70% of cases.
    • In 30% of cases, contralateral testicular involvement follows by 1-9 days.
  • Other rare viral etiologies include coxsackievirus, infectious mononucleosis, varicella, and echovirus.
  • Some case reports have described mumps orchitis following immunization with the mumps, measles, and rubella (MMR) vaccine.
  • Bacterial causes usually spread from an associated epididymitis in sexually active men or men with BPH; bacteria include Neisseria gonorrhoeae, Chlamydia trachomatis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus and Streptococcus species.

    • Bacterial orchitis rarely occurs without an associated epididymitis.
    • Patients are usually sexually active and present with a gradual onset of pain and edema.
    • Unilateral testicular edema occurs in 90% of cases.
  • Immunocompromised patients have been reported to have orchitis with the following etiologic agents: Mycobacterium avium complex, Cryptococcus neoformans, Toxoplasma gondii, Haemophilus parainfluenzae, and Candida albicans.



Epididymitis
Hernias
Testicular Torsion

Other Problems to be Considered

Testicular tumor
Reactive hydrocele
Scrotal pyocele
Torsion of the testicular appendage



Lab Studies

  • Laboratory tests are not helpful in making the diagnosis in the ED.
  • Diagnosing mumps orchitis can be comfortably made based on history and physical examination alone. However, if epididymo-orchitis is a concern, urine dip, urinalysis, and urethral cultures should be obtained.
  • Diagnosing mumps orchitis can be confirmed with serum immunofluorescence antibody testing.

Imaging Studies

  • Color Doppler ultrasonography has become the imaging test of choice for the evaluation of an acute scrotum.

    • Because orchitis often presents as acute edema and pain of the testicle, ruling out testicular torsion is critical.
    • Often the history and the physical examination are enough; however, as an adjunct, ultrasonography is highly sensitive for ruling out testicular torsion and for demonstrating inflammation of the testis or the epididymis.

Procedures

  • If torsion is likely or if several hours have passed before the patient arrives in the ED, operative exploration is indicated.
  • Orchitis complicated by a reactive hydrocele or pyocele may require surgical drainage to reduce the pressure in the tunica.



Emergency Department Care

  • Supportive treatment

    • Bed rest
    • Hot or cold packs for analgesia: Elevation of the scrotum and placement of ice on the affected testis are specific comfort measures that should be recommended to the patient with orchitis. The patient should put a small pillow or a towel between the legs to elevate the scrotum and place ice on the affected testis for 10-15 minutes, 4 times a day, until pain resolves.
  • Most importantly, the ED physician must rule out testicular torsion, as the two syndromes often present with similar symptoms.
  • Second, the ED physician should consider epididymo-orchitis and, if highly suspected, treat appropriately.

Consultations

  • If torsion is likely, urologic consultation is required for urgent surgical exploration.
  • If a significant hydrocele is detected or suspected, urologic consultation is necessary to evaluate the need for a surgical tapping to relieve the pressure on the tunica.
  • Follow-up care with a urologist is appropriate for an uncomplicated presentation of orchitis.



No medications are indicated for the treatment of viral orchitis.

Bacterial orchitis or epididymo-orchitis requires appropriate antibiotic coverage for suspected infectious agents. In patients with a bacterial etiology who are younger than 35 years and sexually active, antibiotic coverage for sexually transmitted pathogens (particularly gonorrhea and chlamydia) with ceftriaxone and either doxycycline or azithromycin is appropriate. Fluoroquinolones are no longer recommended by the Centers for Disease Control and Prevention (CDC) for treatment of gonorrhea because of resistance. For more information see, CDC updated gonococcal treatment recommendations (April 2007).

Patients older than 35 years with bacterial etiology require additional coverage for other gram-negative bacteria with a fluoroquinolone or TMP-SMX. Other appropriate medications include analgesics or antiemetics, as needed.

Drug Category: Antibiotics

Therapy must cover all likely pathogens in the context of the clinical setting.

Drug NameCeftriaxone (Rocephin)
DescriptionThird-generation cephalosporin with broad-spectrum, gram-negative activity; lower efficacy against gram-positive organisms; higher efficacy against resistant organisms. Arrests bacterial growth by binding to one or more penicillin-binding proteins. Used because of an increasing prevalence of penicillinase producing Neisseria gonorrhoeae.
Adult Dose125-250 mg IM once
Pediatric Dose<7 days: Not established
>7 days: 25-50 mg/kg/d IV; not to exceed 125 mg/d
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase ceftriaxone levels; coadministration with ethacrynic acid, furosemide, and aminoglycosides may increase nephrotoxicity
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in renal impairment; caution in breastfeeding women and allergy to penicillin (10% cross-sensitivity exists)

Drug NameDoxycycline (Vibramycin, Doryx)
DescriptionInhibits protein synthesis and bacterial growth by binding to 30S and possibly 50S ribosomal subunits of susceptible bacteria.
Used in combination with ceftriaxone for the treatment of gonorrhea.
Adult Dose100 mg PO bid for 7 d
Pediatric Dose<8 years: Not recommended
>8 years: 2-5 mg/kg/d PO in 1-2 divided doses; not to exceed 200 mg/d
ContraindicationsDocumented hypersensitivity; severe hepatic dysfunction
InteractionsBioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; tetracyclines can increase hypoprothrombinemic effects of anticoagulants; tetracyclines can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy
PregnancyD - Unsafe in pregnancy
PrecautionsPhotosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; tetracycline use during tooth development (last one half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconlike syndrome may occur with outdated tetracyclines

Drug NameAzithromycin (Zithromax)
DescriptionTreats mild-to-moderate infections caused by susceptible strains of microorganisms.
Indicated for chlamydia and gonorrheal infections of the genital tract.
Adult Dose1 g PO once for chlamydial infections
2 g PO once for chlamydial and gonococcal infections
Pediatric Dose10 mg/kg PO once; not to exceed 250 mg/d
ContraindicationsDocumented hypersensitivity; hepatic impairment; do not administer with pimozide
InteractionsMay increase toxicity of theophylline, warfarin, and digoxin; effects are reduced with coadministration of aluminum and/or magnesium antacids; nephrotoxicity and neurotoxicity may occur when coadministered with cyclosporine
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsSite reactions can occur with IV route; bacterial or fungal overgrowth may result with prolonged antibiotic use; may increase hepatic enzymes and cholestatic jaundice; caution in patients with impaired hepatic function, prolonged QT intervals, or pneumonia; caution in hospitalized, geriatric, or debilitated patients

Drug NameTrimethoprim and sulfamethoxazole (Bactrim DS, Septra DS)
DescriptionInhibits bacterial growth by inhibiting synthesis of dihydrofolic acid. Commonly used in patients >35 y with orchitis.
Adult Dose160 mg TMP/800 mg SMZ PO q12h for 14 d
Pediatric Dose<2 months: Do not administer
>2 months: 15-20 mg/kg/d, based on TMP, PO tid/qid for 14 d
ContraindicationsDocumented hypersensitivity; megaloblastic anemia due to folate deficiency
InteractionsMay increase PT when used with warfarin (perform coagulation tests and adjust dose accordingly); coadministration with dapsone may increase blood levels of both drugs; coadministration of diuretics increases incidence of thrombocytopenia purpura in elderly persons; phenytoin levels may increase with coadministration; may potentiate effects of methotrexate in bone marrow depression; hypoglycemic response to sulfonylureas may increase with coadministration; may increase levels of zidovudine
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsDiscontinue at first appearance of skin rash or sign of adverse reaction; obtain CBCs frequently; discontinue therapy if significant hematologic changes occur; goiter, diuresis, and hypoglycemia may occur with sulfonamides; prolonged IV infusions or high doses may cause bone marrow depression (if signs occur, give 5-15 mg/d leucovorin); caution in folate deficiency (eg, chronic alcoholics, elderly persons, those receiving anticonvulsant therapy, or those with malabsorption syndrome); hemolysis may occur in G-6-PD deficient individuals; AIDS patients may not tolerate or respond to TMP-SMZ; caution in renal or hepatic impairment (perform urinalyses and renal function tests during therapy); give fluids to prevent crystalluria and stone formation

Drug NameOfloxacin (Floxin)
DescriptionPenetrates prostate well and is effective against C trachomatis. A pyridine carboxylic acid derivative with broad-spectrum bactericidal effect. Used commonly in patients >35 y diagnosed with orchitis.
Adult Dose400 mg PO bid for 14 d
Pediatric Dose<18 years: Not recommended
>18 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsAntacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; reduces therapeutic effects of phenytoin; probenecid may increase concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT)
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsIn prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy

Drug NameCiprofloxacin (Cipro)
DescriptionFluoroquinolone with activity against pseudomonads, streptococci, MRSA, S epidermidis, and most gram-negative organisms, but no activity against anaerobes. Inhibits bacterial DNA synthesis and consequently growth. Continue treatment for at least 2 d (7-14 d typical) after signs and symptoms have disappeared. Used commonly in patients >35 y diagnosed with orchitis.
Adult Dose500 mg PO bid for 14 d
Pediatric Dose<18 years: Not recommended
>18 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsAntacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; reduces therapeutic effects of phenytoin; probenecid may increase serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsIn prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy



Further Outpatient Care

  • Supportive therapy
    • Bed rest

    • Scrotal support

    • Warm or cold packs for comfort

    • Analgesics

  • Patients with a suspected sexually transmitted disease should be referred to their private physician or local health department for HIV testing.

Complications

  • Up to 60% of affected testes demonstrate some degree of testicular atrophy.
  • Impaired fertility is reported at a rate of 7-13%.
  • Sterility is rare in cases of unilateral orchitis.
  • An associated hydrocele or pyocele may require surgical drainage to relieve pressure from the tunica.

Prognosis

  • Most cases of mumps orchitis resolve spontaneously in 3-10 days.
  • With appropriate antibiotic coverage, most cases of bacterial orchitis resolve without complication.

Patient Education



Medical/Legal Pitfalls

  • ED physicians must be certain that a patient presenting with acute testicular pain and edema does not have testicular torsion.



The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, Peter Moyer, MD, to the development and writing of this article.



  • Basekim CC, Kizilkaya E, Pekkafali Z, Baykal KV, Karsli AF. Mumps epididymo-orchitis: sonography and color Doppler sonographic findings. Abdom Imaging. May-Jun 2000;25(3):322-5. [Medline].
  • Blaivas M, Sierzenski P, Lambert M. Emergency evaluation of patients presenting with acute scrotum using bedside ultrasonography. Acad Emerg Med. Jan 2001;8(1):90-93. [Medline].
  • Casella R, Leibundgut B, Lehmann K, Gasser TC. Mumps orchitis: report of a mini-epidemic. J Urol. Dec 1997;158(6):2158-61. [Medline].
  • Cook JL, Dewbury K. The changes seen on high-resolution ultrasound in orchitis. Clin Radiol. Jan 2000;55(1):13-8. [Medline].
  • Corbett HJ, Simpson ET. Management of the acute scrotum in children. ANZ J Surg. 2002;72(3):226-8. [Medline].
  • Dogra V, Bhatt S. Acute painful scrotum. Radiol Clin North Am. Mar 2004;42(2):349-63. [Medline].
  • Edelsberg JS, Surh YS. The acute scrotum. Emerg Med Clin North Am. Aug 1988;6(3):521-46. [Medline].
  • Herbener TE. Ultrasound in the assessment of the acute scrotum. J Clin Ultrasound. Oct 1996;24(8):405-21. [Medline].
  • Manson AL. Mumps orchitis. Urology. 2004;36(4):355-8. [Medline].
  • Rosenstein D, McAninch JW. Urologic emergencies. Med Clin North Am. Mar 2004;88(2):495-518. [Medline].
  • Masarani M, Wazait H, Dinneen M. Mumps orchitis. J R Soc Med. Nov 2006;99(11):573-5. [Medline].
  • Gift TL, Owens CJ. The direct medical cost of epididymitis and orchitis: evidence from a study of insurance claims. Sex Transm Dis. Oct 2006;33(10 Suppl):S84-8. [Medline].
  • Shafik A, El-Sibal O, Shafik I. Electro-orchidogram: a non-invasive diagnostic tool in testicular pathologies. Med Sci Monit. Aug 2006;12(8):MT51-5. [Medline].
  • Schalamon J, Ainoedhofer H, Schleef J, Singer G, Haxhija EQ, Hollwarth ME. Management of acute scrotum in children--the impact of Doppler ultrasound. J Pediatr Surg. Aug 2006;41(8):1377-80. [Medline].
  • Lane TM, Hines J. The management of mumps orchitis. BJU Int. Jan 2006;97(1):1-2. [Medline].

Orchitis excerpt

Article Last Updated: Jul 2, 2007